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Abstract
Background: We have co-designed a tailored blended physiotherapy intervention for people with progressive
multiple sclerosis (PwPMS) who often struggle to access support for physical activity. Underpinned by self-
management principles, the Lifestyle, Exercise and Activity Package for people with Multiple Sclerosis (LEAP-MS)
intervention incorporates face-to-face or online physiotherapy coaching sessions with an accompanying online
physical activity platform. The LEAP-MS platform is a multi-user system enabling user and physiotherapist to co-
create activity plans. The LEAP-MS platform consists of an information and activity suite, interactive components
enabling selection of exercises into an activity programme, goal setting and activity logging. The platform also
facilitates online remote support from a physiotherapist through an embedded online messaging function. We aim
to evaluate the LEAP-MS platform in a feasibility trial.
Methods: LEAP-MS will be evaluated within a single-arm feasibility study with embedded process evaluation. After
registration and initial eligible screening, 21 participants will be required to complete baseline self-completion
measures. This will be followed by an initial home-based or online coaching session with a physiotherapist (who
has received tailored self-management and digital resource training) and access to the online intervention for an
initial 3-month period. During this period, participants are given the option to request up to five further home-
based or online physiotherapy coaching sessions. Follow-up questionnaires and semi-structured interviews will be
administered 3 months after baseline with participants and intervention physiotherapists. The LEAP-MS platform will
be available to participants for a further 3 months. Usage of the LEAP-MS platform will be tracked during the full 6-
month period and final follow-up will be conducted 6 months after baseline.
Discussion: Feasibility outcomes (recruitment, retention, intervention uptake and safety) will be reported. The
process evaluation will be undertaken to identify possible mechanisms for any observed effects. The data will
inform full-scale evaluations of this co-produced, blended physiotherapy intervention.
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Background
Multiple sclerosis (MS) is the most common disabling
neurological disease among young adults [1] affecting an
estimated 107,000 people in the UK [2]. MS is charac-
terised by focal areas of inflammatory demyelination
within the central nervous system. In the early phase of
MS, most people experience discrete episodes of neuro-
logical dysfunction (relapses). However, around half of
people with relapse-onset MS tend to develop an insidi-
ous deterioration in disability after 30 years from onset,
which is described as secondary progressive disease [3,
4]. In addition, around 10% of people with MS do not
experience relapses at onset, but rather present with an
insidious accumulation of neurological disability, which
continues to progress with or without superimposed re-
lapses, termed primary progressive MS [3, 5].
In the UK, it is estimated that 10–15,000 have primary
progressive MS [6] and 38,000 have secondary progres-
sive MS [7, 8]. People with progressive MS (PwPMS)
tend to have higher levels of disability than those with
relapsing-remitting MS, often have high health and so-
cial care needs and self-report low health-related quality
of life [9, 10]. PwPMS experience a wide range of symp-
toms including motor, sensory, visual, bowel and bladder
dysfunction [11].
Physiotherapists play a central role as part of a
multidisciplinary team of healthcare professionals who
support people with progressive multiple sclerosis in
the management of their symptoms [12]. Primarily fo-
cussed on maintaining, adapting or enhancing phys-
ical and sensory capabilities of individual patients,
physiotherapy has been shown to be effective in, for
example, improving balance [13], mobility [14] and
spasticity [15] with people with MS. As part of their
therapeutic toolkit, physiotherapists use exercise and
have expertise in supporting and promoting physical
activity [16].
Physical activity is ‘any bodily movement produced by
skeletal muscles that requires energy expenditure’ [17]
and relates to activities of daily living which are con-
ducted through movement and activities with physical/
movement components which are carried out as part of
work, leisure or recreation—including walking or wheel-
ing, sports, play etc. The physical activities we undertake
both define and can be shaped by our lifestyle—simply
defined as the way in which we live—relating to everyday
behaviours and activities including work, leisure and diet
[18, 19]. The interconnectedness of these concepts re-
quires the context within which people live to be taken
into consideration when exploring how to support
people to be physically active.
Regular physical activity is generally regarded to be an
important component of the long-term management of
MS. Positive outcomes of regular physical activity in-
clude improved mobility, strength and cognition and re-
duced fatigue [20–22]. There are also well-established
psychological and social benefits associated with physical
activity in MS [23, 24], and engaging in regular physical
activity is considered to be a positive way to cope with
living with progressive MS [25, 26].
Engaging with physical activity significantly enough to
benefit from such outcomes, however, relies on changing
behaviours. Behaviour change theories (theories and
models which seek to explain why people behave the
way they do and what is required to alter what they do
and how they think) are therefore often selected to
underpin the development and testing of physical activ-
ity interventions—known as ‘behaviour change interven-
tions’ [27].
Although physical activity interventions can be based
on a plethora of behaviour change theories, aspects of
social cognitive theory and self-regulation theory [28,
29] are widely drawn upon. The key constructs within
these theories are those of self-efficacy and self-
regulation. Self-efficacy is defined as ‘the belief in one’s
capabilities to organize and execute the courses of action
required to manage prospective situations’ [28]. It forms
part of self-regulation, the processes of ‘self-monitoring
of one’s behaviour, its determinants, and its effects; it
also includes judgment in relation to personal standards
and environmental circumstances; and affective self-
reaction’ [29]. Methods used to implement these con-
structs overlap and include goal setting, feedback and
guided practice.
Various physical activity interventions for people with
MS have been reported in the literature, ranging from
group-based to digital versatile disc (DVD) and web-
based interventions [30–34]. A recent systematic review
which evaluated the effectiveness of behavioural change
interventions aiming to increase activity and participa-
tion in people with MS found that short duration inter-
ventions incorporating goal setting, barrier identification
and information provision increased physical activity
[27]. These, and more recent research exploring physical
activity interventions and factors impacting physical ac-
tivity levels for people with MS, highlight how develop-
ing self-determined and self-efficacious physical activity
behaviours through goal setting, appropriate
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communication and self-monitoring are critically im-
portant determinants of sustained physical activity be-
haviour [35–37].
Despite the potential benefits of physical activity and
the value placed on supporting people with MS to re-
main active, there remains little evidence about the ben-
efits of physiotherapy or physical activity for PwPMS
who have more advanced disability [38]. Most research
has focussed on patients who are ambulatory, despite
non-ambulatory people with MS being those who are
least likely to stay active [23, 39, 40]. A systematic review
[41] of physiotherapy interventions, including exercise
therapy, for the rehabilitation of people with progressive
multiple sclerosis published in 2016 reviewed 13 studies
(of eight interventions) of variable methodological qual-
ity. It concluded that physiotherapy and exercise inter-
ventions for PwPMS were potentially of benefit but that
fully powered efficacy studies were required. Recently, a
home-based, self-managed standing frame programme
has been found to be effective in PwPMS [42]; however,
there is little research into physical activity interventions
in PwPMS, which may be explained by difficulties
recruiting or retaining individuals with advanced disabil-
ity into research studies. These challenges, which may be
explained by difficulties travelling to appointments and a
high prevalence of fatigue and cognitive impairment, are
the same ones that must be overcome to enable PwPMS
to engage in sustained physical activity. Seeking sustain-
able, cost-effective interventions that facilitate access to
physical activity for all remains a priority.
Despite the limited evidence about the benefits of
physical activity for PwPMS, we know that people
with MS, including those with progressive MS, want
to keep physically active and moving [25, 43]. How-
ever, people with MS, especially those who are more
disabled, find it hard to start and to maintain activity
[44]. Many require support to remain physically active
and often do not receive enough support [44]. When
people with MS are asked about their needs,
physiotherapist-led support for physical activity ranks
highly [45–47] with many needing support to identify
physical activity that is suited to them [48, 49]. Phys-
iotherapists’ training and experience mean that they
are ideally placed to support physical activity and ex-
ercise prescription and are often promoted as exercise
experts [50]. This expert role, however, may paradox-
ically foster reliance on physiotherapists, and although
many physiotherapists have a thorough knowledge of
risk factors, pathology and their effects on all systems,
they may not necessarily be confident in exercise
physiology and prescription. Indeed, the first barrier
to promoting activity in PwPMS may come not from
the individual themselves, but from the professionals
with whom they engage [51, 52].
Here we present the protocol for the LEAP-MS single-
arm feasibility trial and embedded process evaluation.
Underpinned by social cognitive theory and self-
regulation theory, taking a self-management approach—
LEAP-MS is a co-designed blended physiotherapy digital
intervention [53]. Our primary objective is to establish
the feasibility of the LEAP-MS intervention. Secondary
to this, we will validate the underpinning intervention
logic model through both qualitative assessment of
intervention processes and descriptive evaluation of ac-
ceptability and patient-reported outcomes.
Methods
Study design summary and setting
This is a single-arm feasibility study with an embedded
process evaluation. Those who are eligible and consent
to participate in the study will complete a series of self-
completed assessments at baseline, 3 and 6 months; dur-
ing this time, they will also have access to the LEAP-MS
blended physiotherapy intervention (see Fig. 1; partici-
pant flow diagram). The intervention will be delivered
online and, where possible, face-face in participants’
homes. Home-based delivery is reliant upon the current
COVID-19 pandemic social distancing requirements be-
ing lifted and/or local physiotherapy provision.
The intervention comprises physiotherapy coaching
sessions (delivered via a secure web video conferencing
system or in person where possible) and an online plat-
form. The online platform consists of a series of co-
produced resources and functions. These include online
interactive education, an activity selection and planning
tool, specifically developed for PwPMS and a
participant-physiotherapist messaging system. The activ-
ity selection and planning tool includes tailored physical
activity ideas and interactive functions enabling the de-
velopment of personalised activity programmes, goal set-
ting and activity logs. The online platform works in
conjunction with remote or face-to-face coaching ses-
sions and facilitates remote support (via the online plat-
form messaging system) from trained physiotherapists.
Population
We will recruit 21 participants with either primary or
secondary progressive multiple sclerosis (as defined by
the Lublin classification) [3] who are aged 18 or over
and who have an Expanded Disability Status Scale
(EDSS) score [54] between 6 and 8. The EDSS scale
ranges from 0 to 10 in 0.5 unit increments that represent
greater levels of disability. EDSS steps 5.0 to 9.5 are de-
fined by the impairment to walking—with people scoring
6–8 on the scale ranging from someone requiring a
walking aid to walk 100m to someone who is largely re-
stricted to a chair or wheelchair, but who maintains
functional use of their arms. Participants will be required
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Fig. 1 Participant flow diagram
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to have the capacity to consent to study participation on
their own behalf and have access to mobile, wireless or
wired Internet connection at home. We will exclude any
individuals with relapsing-remitting or non-progressive
MS, those who are unable to understand written and
spoken English or those whose who are pregnant or
planning a pregnancy.
The sample size is based on the 95% confidence inter-
val for an adequate proportion of eligible subjects being
recruited (70%). The lower 95% confidence interval is
50% which is the minimum acceptable recruitment
proportion.
Recruitment
There will be three routes for informing potential partic-
ipants about the study: (1) Eldrix HealthContact, (2) out-
patient physiotherapy services or (3) MS Society branch
and national MS register publicity in the local region.
1) Eldrix HealthContact is a tertiary centre MS
database where PwPMS who meet the inclusion
criteria and who have also given consent to be
contacted about research will be identified by
authorised Eldrix HealthContact users. A selection
of those identified (based on EDSS scores in
potentially eligible range) will be sent a study
information sheet.
2) Physiotherapists at the two participating Health
Boards will screen all MS outpatients for eligibility
during the recruitment phase. Those eligible and
interested in participating will be provided with an
information sheet about the study.
3) Information about the study will be made available
via the local branch of the MS Society (within the
boundaries of the two participating Health Boards)
and the UK MS Register inviting interested
participants to complete the online expression of
interest.
Those interested in participating will be required to
complete an online expression of interest form and eligi-
bility checklist via the LEAP-MS website. The expression
of interest includes confirmation of MS diagnosis and
EDSS self-completion. All participants recruited via the
Eldrix HealthContact will have a consultant confirmed
diagnosis of MS prior to entry into the database but re-
cruitment via other routes relies on self-reporting. Hav-
ing a self-enrolment option however is aimed at
enhancing accessibility and inclusivity.
We will monitor population characteristics of those
who express an interest in participating (age, gender and
levels of disability). The expression of interest form will
remain open until such time as eligibility has been con-
firmed for the entire recruited participant cohort. This
will take the form of a two-stage process. First, prior to
the initial target sample size being recruited, those who
submit an expression of interest will receive an automat-
ically generated response from the system. The message
will thank them for their interest and explain that eligi-
bility will be assessed in the order of expression of inter-
est receipt and that the study team will contact them in
due course. Second, once eligibility has been confirmed
for the entire participant cohort and the study has closed
to recruitment, the expression of interest page will dis-
abled; however, interested individuals will be able to pro-
vide their contact details to receive study updates and
results.
Eligibility screening and informed consent
Those who complete an online eligibility checklist and
are deemed potentially eligible will receive a telephone
call from the research team, to discuss what participa-
tion in the study involves and be given the opportunity
to ask any questions. Their eligibility will be checked
during this call and fully confirmed by their physiother-
apist at the first coaching session. Those participants
who are interested in the study will be directed back to
the LEAP-MS website and provided with individual user
details to complete an online consent form. Once the
consent form has been submitted online, participants
will be directed to complete the baseline assessment
battery.
Assessments
All participants will be required to complete a range of
patient-reported outcome measures directly online at
baseline, 3 and 6 months post-baseline (plus or minus 2
weeks; see Table 1: schedule of enrolment, interventions
and assessments). Selected assessments were reflective of
our logic model of change, linking performance objec-
tives to the proposed intervention outcomes over the
short and medium terms [53]. In the shorter term, we
anticipated that adherence to the intervention would be
achieved through enhanced self-efficacy as assessed by
the University of Washington 6-item short from self-
efficacy scale (UW-SES-SF) (MS specific) [55]. This
would then in turn influence the impact of ill-health on
participation, activities and autonomy as measured by
the Oxford Participation and Activities Questionnaire
(OxPAQ) [56] and health-related quality of life as mea-
sured by EQ-5D-5L [57]. In the longer term, we
hypothesised that the intervention would reduce the im-
pact of the Fatigue Impact Scale (MFIS-29) [58] and the
physical and psychological impact of MS from the pa-
tient’s perspective as measured by the Multiple Sclerosis
Impact Scale (MSIS-29) [59]. A further consideration
was participant burden and the need for self-completion
measures to facilitate the remote assessment. Each of
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these measures has been validated for self-completion by
people with multiple sclerosis.
After the baseline assessments have been completed
by the participant, their online user account will be
paired with an intervention physiotherapist’s account.
This physiotherapist will then contact the participant to
arrange the first coaching session, after which the full
LEAP-MS online tool will be released to the participant.
Participants will be asked to repeat the online patient-
reported outcome measures, plus a modified Patients’
Global Impression of Change (PGIC) [60], at 3 months
and 6 months post-baseline. In this, they will be asked
to indicate their degree of change using one of five re-
sponses (much better, slightly better, the same, slightly
worse, much worse) in relation to their routine activities,
emotional well-being and social engagement.
Automatic prompts will be provided to the registration
email address at the start of the follow-up data collection
window (2 weeks before and 2 weeks after the expected
assessment completion date). Participants will receive a
telephone reminder if they have not logged on in the 2
weeks prior to the expected assessment completion date.
Electronic data capture will be standardised across all
study remote processes using an online platform devel-
oped by the Centre for Trials Research using a bespoke
Structured Query Language (SQL) database. A study-
specific data management plan has been developed to
ensure the security and confidentiality of all participant
data and that high-quality data is available for ongoing
analyses.
At the end of the initial intervention period (3
months), participants and their treating physiotherapists
will be asked to participate in a semi-structured inter-
view aimed at eliciting experiences and reflections on
the intervention, and the process of its delivery (content,
design, language, adaptability to personal needs and rec-
ommendations for the future). Given the small sample
size of this feasibility study, everyone who consents to
being interviewed will be interviewed, even if they with-
draw from the intervention (see the ‘Process evaluation’
section). Interviews will be conducted by a research team
member who is not involved in the intervention delivery
but is a physiotherapist by background and an experi-
enced qualitative researcher.
LEAP-MS intervention
The aim of the LEAP-MS intervention is to provide im-
proved awareness of achievable, relevant and interesting
activities and exercises for PwPMS. It will also provide
an opportunity for sharing experiences of participating
and enable shared management and monitoring (self
and physiotherapist) of activities and exercises. It is a
Table 1 Schedule of enrolment, interventions and assessments
Study period












Pre-screening—Eldrix HealthContact Database X
Pre-screening—physiotherapy outpatient clinics X
Self-assessment online eligibility check X
Eligibility screen and discuss the study (telephone call from research
team)
X
Online informed consent X
Eligibility confirmed at physiotherapy coaching session X
Intervention
Physiotherapy coaching sessions (up to 6 sessions) X
LEAP-MS activity web-based platform X X
Assessments
MFIS X X X
MSIS-29 X X X
EQ-5D-5L X X X
OxPAQ X X X
UW-SES-SF X X X
PGIC X X
Semi-structured interview X
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blended physiotherapy intervention made up of (1) a co-
produced, encrypted multi-user web-based platform ac-
cessible to participants and physiotherapists and (2)
coaching sessions with intervention physiotherapists de-
livered via a secure web video conferencing system, or in
person, in the participant’s home. Intervention physio-
therapists are trained on self-management principles and
practice, use of technology in coaching sessions and
physical activity and exercise guidelines for neurological
conditions. As this is a blended intervention including a
web-based platform, participants will require computer
skills (or a carer companion who can assist them is
needed) and Internet access for the duration of their
study participation.
The LEAP-MS online platform
The platform is specifically developed for PwPMS and
includes regularly updated multimedia education about
being active with PMS, tailored physical activity ideas
and interactive functions enabling the development of
personalised activity plans, goal setting and the monitor-
ing of activity through activity logs. Activities are dis-
played in an ‘activity suite’ grouped into categories, e.g.
cardiovascular, strengthening, balance, flexibility, pelvic
health etc., and include a large range of exercise videos
from aerobics to seated boxing to tai chi. These sit
alongside other, more specific exercises described or
demonstrated through text and images. Each exercise or
activity suggestion can be selected and added to an ‘ac-
tivity plan’, enabling participants to select individual ac-
tivities to try. In addition, participants are able to set and
monitor personalised goals using a goal-setting function
and input all activity undertaken through the use of an
activity log. A fuller description and images of the inter-
vention are described elsewhere [53].
The LEAP-MS platform enables access and data input
options via desktop computers, laptops, tablets or smart
phones. Participants, physiotherapists and the research
team all have different access rights to and editing per-
missions for the LEAP-MS platform. Participants use
the platform to register; complete eligibility forms,
consent, baseline and follow-up measures; input safety
information; and access the interactive education and
activity selection and planning tool. They are also en-
abled to contact their intervention physiotherapist via
a messaging function to ask questions, seek guidance
or request coaching sessions. Physiotherapists use the
platform to record coaching session notes, respond to
participant questions and requests and view partici-
pant activity selections and goal setting. The platform
is also used by the study team to evaluate participant
engagement with the intervention and to manage data
throughout the study.
LEAP-MS coaching sessions
LEAP-MS participants will meet with an intervention
physiotherapist up to six times, remotely or face-face in
their own homes. During coaching sessions, participants
will be shown how to navigate and use the LEAP-MS
online platform as required, select suitable activities,
form an activity plan and set and review activity goals.
Drawing on both their professional knowledge and train-
ing underpinned by the Bridges self-management ap-
proach [61], people with MS are taught how to utilise
self-efficacious and self-regulatory practices throughout
the consultations. Critically, physiotherapists will not in-
struct, or prescribe activity to participants—but instead
use coaching techniques and open questioning to con-
sider meaningful activities they would like to try and
support participants to set goals, log activity and moni-
tor their progress. Through discussion, physiotherapists
will support participants to identify potential barriers
(e.g. their own motivation, habits, environmental or so-
cial factors) and pre-plan ways to overcome these bar-
riers should they arise. Following a mandatory initial
coaching session, participants will be able to request up
to five further coaching sessions and/or communicate
via a messaging function described below.
Participant use of the LEAP-MS platform and interaction
with physiotherapists
In the initial 3-month intervention period, participant
use of the LEAP-MS platform works in conjunction with
support from intervention-trained physiotherapists and
includes a user pairing facility where patient users are
paired with an intervention physiotherapist. The physio-
therapist can view the activity selections and goals set by
the patient participant and provide coaching and support
to engage with participants in setting small targets and
incorporating physical activity into their everyday life.
The web-based platform also has an in-built messaging
function to enable participants to contact their physio-
therapist in the initial 3-month period to ask questions,
seek guidance about activity engagement and request up
to six coaching sessions. Coaching sessions will be con-
ducted at participant’s homes or online dependent on
participant preference whilst accommodating any local
restrictions (e.g. social distancing during COVID-19 or
staff availability—see [62] for COVID-19 study adapta-
tions). When conducted online, coaching sessions will
be conducted via a secure web video conferencing sys-
tem. All interactions (whether in person, via web video
conferencing or via the in-built platform messaging sys-
tem) will operationalise a supported self-management
approach to regular physical activity. Physiotherapists
will not be required to respond immediately to commu-
nication through the platform, but will schedule regular
time slots to respond to LEAP-MS communication, as
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they would with other forms of patient communica-
tion—such as returning telephone calls from outpatients
or family members. They will aim to respond within 5
working days. A pre-specified inactivity period of 21
days on the website by any one participant will automat-
ically be logged and flagged to the corresponding patient
participant’s physiotherapist, who will then contact the
participant to offer any further support.
Interactions between participant and physiotherapist
using the in-built platform messaging function will be
captured by the study database. Notes of coaching ses-
sions will be recorded in the web platform and down-
loaded for adding to patient notes. Where face-to-face
coaching sessions are conducted, intervention physio-
therapists will be required to detail distance travelled,
mode of travel time and face-to-face contact time. For
coaching sessions delivered via web video conferencing,
only video conferencing time will be detailed.
Physiotherapist training
All intervention physiotherapists will receive bespoke
LEAP-MS training, which delivers (1) real-time training
(either face-face or remotely) about self-management
principles and how to integrate these into contacts with
patients, (2) how to use online conferencing as a method
of communication and providing consultations, (3) how
to introduce/instruct patients in the use of online con-
ferencing and online resources (in this case the LEAP-
MS platform) and (4) a clinical update on physical activ-
ity and exercise guidelines for use with people with
neurological conditions. The training package consists of
real-time training days (delivered face-face or remotely)
and an online self-study resource. The real-time self-
management training workshops are delivered by experi-
enced facilitators from Bridges Self-Management (http://
www.bridgesselfmanagement.org.uk/). Paper-based
learning materials traditionally accompanying face-face
training workshops and video-recorded films from the
training have been digitised and housed in an online
learning platform for use by intervention physiothera-
pists to refer back to as required. Given the emergent
challenges in rehabilitation service delivery during the
COVID-19 pandemic, and the anticipated move to
greater use of remote intervention delivery, further re-
sources (https://www.bridgesselfmanagement.org.uk/
covid-19-resources/) to help structure remote interac-
tions were also made available as part of the final train-
ing package to ensure standardisation of coaching
interactions regardless of the mode of delivery (online or
face to face in the home). In addition, an accompanying
online training resource included video-recordings with
experienced physiotherapists with expertise in the use of
digital technologies in practice to provide guidance on
the use of technology in coaching sessions and videos
with an expert in exercise prescription for people with
neurological conditions to teach core principles of exer-
cise physiology and prescription [63, 64]. Intervention
physiotherapists are required to watch and work through
these additional learning materials independently.
The physiotherapists who complete the training will
be invited to participate in the LEAP-MS study as ‘inter-
vention physiotherapists’. All those who consent to tak-
ing part will have access to conversation-based scripts
that they can use to guide their coaching conversations
(primarily for online use). They will also have the oppor-
tunity to practice coaching conversations and receive
peer review. They will be asked to take part in interviews
to share their experience of intervention training and
intervention delivery.
Safety
We will assess and record any adverse events that may
be reported.
Expected adverse events (AEs) In this patient popula-
tion, hospitalisation due to MS, acute illness resulting in
hospitalisation, new medical problems and deterioration
of existing medical problems are expected. This informa-
tion will be self-reported by patients online and will not
be subject to expedited reporting; however, it will be
reviewed on a monthly basis by the study team. The
physical activity intervention does not specifically in-
volve any heavy load-bearing exercise or heavy eccentric
muscle activity. However, some minor muscle soreness
or muscular strain may occur in the few days following
the initiation of a new exercise programme or increased
physical activity. This would normally resolve spontan-
eously and would not require any specific interventions
or additional medical care but will be noted as a poten-
tial expected related AE if reported during the 3-month
intervention period. Falls and fatigue are an expected AE
as part of the clinical condition but will be monitored
for the duration of the intervention.
Procedure Participants will be asked to use the LEAP-
MS platform to self-report any incidents of falls, fatigue,
increased muscle soreness or sprain, or other incidents
they feel are relevant, and whether the incident required
medical intervention. Selecting that medical intervention
was required will trigger an automated prompt to the
paired physiotherapist. Similarly, no activity on the on-
line platform for 3 weeks will also trigger an automated
prompt to the paired physiotherapist. Once prompted,
the paired physiotherapist will contact the participant to
discuss the incident. All serious adverse events (SAEs)
that occur between the time of consent and the 3-month
follow-up must be reported immediately to the Centre
for Trials Research (within 24 h of knowledge of the
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event) by the intervention therapist using a dedicated
SAE form, unless the SAE is specified as not requiring
immediate reporting.
Planned analyses Analyses will be guided by the CON-
SORT extension for pilot and feasibility studies [65].
The primary objectives are to establish feasibility of the
study in terms of quantitative measures of recruitment,
retention, intervention uptake and safety (see Table 2).
All proportions will be tabulated with 95% confidence
intervals alongside the CONSORT chart, which will de-
tail the reasons for exclusion, refusal and dropout. Inter-
vention uptake will be reported descriptively. There is
no defined minimum dataset for the clinical secondary
outcomes. Data completeness of each patient-reported
outcome measure will be tabulated and will further in-
form our assessment of feasibility. Distributions of the
outcome scores will be investigated and appropriate
summary measures for the whole group tabulated with
95% confidence intervals at baseline and follow-up time
points. An assessment of attrition bias will be made via
tabulation of baseline characteristics for those with
complete follow-up data and those who were not
followed up. No formal hypothesis tests will be carried
out in the analyses; however, factors such as disease se-
verity (as represented by EDSS scores) and self-efficacy
(measured by UW-SES) that may plausibly impact on
adherence and retention will be explored with graphical
displays. The traffic light system (green, amber, red) of
progression criteria as proposed by Avery et al. [66] will
be utilised (see Table 2) to guide our decisions as to fu-
ture evaluations.
If at the end of the study the feasibility progression cri-
teria are achieved, then the recommendation would be
to move to a randomised evaluation. Modifications in
the trial processes or the intervention may be required if
progression criteria are not fully achieved. If there is not
an identifiable reason or remediable action that can be
taken, then progression to a full trial would not be
recommended.
Intervention uptake and safety are not formal progres-
sion criteria in this single-arm feasibility study but will
be closely monitored and considered in any final recom-
mendations for further evaluations. Intervention uptake
will be reflected by (1) the percentage of initial coaching
sessions completed, the number of additional
physiotherapy coaching sessions requested and com-
pleted and the number of remote physiotherapist con-
tacts recorded and (2) frequency and duration of weekly
logged physical activity. Website log in rates and length
of time between each log in episode will provide supple-
mental information on intervention uptake. Safety will
be assessed using an online process of self-reporting by
the participant and from any SAE forms completed by
the intervention therapist.
Process evaluation
The process evaluation will enable an understanding of
the acceptability and fidelity of the intervention, identify
possible mechanisms for any observed effects and learn
about any adaptations made by the participants (PwPMS
and physiotherapists) in undertaking the programme.
Acceptability assessment will focus on content, design,
language and adaptability to personal needs. It will be
assessed through the analysis of any remote contact be-
tween participants and physiotherapists as well as semi-
structured interviews (conducted either face to face or
via the secure web video conferencing system) with par-
ticipants who completed the intervention, those who
withdraw from the study and physiotherapists who de-
liver the intervention. In physiotherapist interviews, we
will collect detailed demographic information so we can
understand how their characteristics (work setting, pre-
vious experience, previous training) influence their ap-
proach, experience of the training and delivering the
intervention.
Fidelity of the LEAP-MS intervention delivery will be
assessed using independent analysis of audio-recorded
and/or observed (sampled) sessions, analysis of partici-
pants’ online activity logs and participant-
physiotherapist communications. Six initial coaching
sessions (approximately 25% of initial coaching sessions)
and between 5 and 10 follow-up coaching sessions
(dependent on participant consent) will be observed and
audio-recorded if conducted face-face. Coaching sessions
conducted via web video conferencing will be recorded
using an in-built recording function.
Actions observed during face-face observations will be
captured using basic proxemic sketches (stick people
drawings) and kinesics (kinesics refers to the nonverbal
movement-related elements of communication in the
creation and sustaining of social interactions), alongside
Table 2 Feasibility outcomes
Feasibility
outcome
Measurement Green Amber Red
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standard ethnographic notations (the description of ac-
tions/happenings as the observer sees them) [67]. The
proxemic and kinesics sketches will serve to record the
physical and spatial interactions between patient, physio-
therapist and intervention technology, to assist the
charting of how learning is delivered and ‘gets done’
through the coaching sessions. If the intervention is de-
livered remotely, coaching sessions will be recorded and
analysed directly.
This range of data collection methods has been se-
lected to enable a comprehensive and multi-faceted de-
scription of the experience of those taking part, a
nuanced understanding of intervention delivery and
usage. The multiple methods selected will also act as a
robust form of triangulation.
All qualitative data collection for the process evalu-
ation will be carried out by a research team member
with qualitative research experience, not involved in
intervention delivery. All data will initially be separated
into their ‘type’, i.e. speech, text or action (observation),
with appropriate methods of analysis applied to each
type of data. Interviews, recorded coaching sessions and
observations will be analysed thematically initially [68].
Should the coaching sessions component of the inter-
vention be found to be central to the usage of the online
platform, discourse analysis may be conducted to better
capture and understand the impact of interaction and
communication between patient participant and physio-
therapist. Data collected from text-based online inter-
action (emails between patient participant and
physiotherapist, goal setting and activity records) will be
considered as ‘personal documents’ and subject to text-
ual analysis methods.
Due to the focus of this process evaluation on the use
of each component of the intervention, the personal
documentation will be initially subjected to content ana-
lysis—with a more detailed thematic analysis applied if
required [69], to assist final synthesis and triangulation
should the depth of the data warrant it. Key findings
from each type of data set will be compared and con-
trasted, drawing out similarities, differences and any
contradictions. Data will be reviewed in light of any con-
tradictions and will guide a member checking process
with participants, which will be conducted prior to the
write-up and dissemination of findings.
Findings will be separated into process and outcome
data ready for reporting but with consideration being
given to where/if the doing of any process is a major
contributor to the outcomes or perceived experience of
participants. At this point, we will explore possible
mechanisms for any observed effects (both for the per-
son with MS and the intervention physiotherapist) so as
to validate change objectives, behavioural outcomes and
patient-reported intermediate and longer-term outcomes
as depicted in the proposed intervention logic model
(Fig. 2). There are training needs for physiotherapy staff
in delivering this intervention. These are reflected in the
physiotherapy component of the logic model as are as-
pects related to the broader context within which this
intervention will be implemented.
Discussion
The LEAP-MS platform is a multi-user system enabling
participants and physiotherapist to co-create activity
plans. The LEAP-MS platform consists of an informa-
tion and activity suite, interactive components enabling
selection of exercises to create an activity programme,
goal setting and activity logging. The platform also facili-
tates remote support from a physiotherapist through an
embedded online messaging function. Our experience
here lays the basis for the development of multi-user
platforms that can be adapted according to population
and trial design.
As the secure, encrypted multi-user web-based plat-
form will be accessible to participants, physiotherapists
and researchers with data input options via desktop
computers, laptops, tablets or smart phones, participants
are able to use the platform to register; complete eligibil-
ity forms, consent, baseline and follow-up measures; and
access the intervention. Participants, physiotherapists
and research administrators all have different access and
editing level permissions within the platform. It is also
used by the study team to evaluate participant engage-
ment with the intervention and to manage data through-
out the study.
Our ambition has been to co-design a model for phys-
ical activity self-management support for PwPMS that is
patient-, family/carer- and community-centred with
physiotherapists providing a unique role as a coach and
partner throughout the whole disease trajectory [70].
Self-management approaches are associated with a re-
duced reliance on health professionals and an increased
sense of autonomy and control over an individual’s con-
dition. Such approaches are also characterised by ups-
killing the individual to anticipate potential barriers to
achieving any specified goals and to problem solve in the
face of such challenges. Any programme, based on self-
management principles, should then, at its heart, address
the fundamental, individual and relational barriers that
typical physio-led interventions may pose. Upskilling
physiotherapists’ self-management support skills along-
side exercise prescription knowledge, sharing expertise
and working collaboratively with people living with pro-
gressive MS to define strategies and activity plans is
more likely to promote physical activity behaviour
change [71].
Unlike other physiotherapy-based online activity plat-
forms for other conditions or general education
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platforms, the LEAP-MS platform has a paired account
function in which people with MS can be paired with their
physiotherapist. Critically, rather than the physiotherapist
selecting and prescribing activities, the person with MS
has complete choice and control of this process. The
physiotherapist can view participant activity logs, but ad-
vise only as required by the person with MS. Furthermore,
the patient-facing element of the LEAP-MS intervention
platform combines multimedia educational content, activ-
ity provision, activity monitoring and goal setting. It in-
cludes an online hub for physiotherapists, which draws
together self-management training and provides a space
for multimedia exercise in long-term neurological
conditions.
Evaluation of feasibility, including intervention uptake
as measured by login rates and duration, and acceptabil-
ity in terms of content, design, language and adaptability
to personal needs will inform modification and future
evaluation. Findings from the feasibility study will be dis-
seminated to participants, healthcare professionals and
the public via a series of outputs. These include a lay
summary of findings to be sent to participants and pub-
lished on university and funder websites for public view-
ing, formal research reports, peer-reviewed publications
and conference papers to share findings with healthcare
professionals.
Trial status The trial is sponsored by Cardiff University
(resgov@cardiff.ac.uk) and is set up. Recruitment will
commence on 01.06.2020 and is anticipated to end on
30.10.2020. This manuscript has been drafted according
to version 1.1 (12/05/2020) of the trial protocol. The
protocol has been written according to the Standard
Protocol Items: Recommendations for Interventional
Trials (SPIRIT) statement (see Fig. 2 and Additional File
1); the intervention is described according to the Tem-
plate for Intervention Description and Replication
(TIDieR) checklist (see Additional File 2); and the final
report will follow the Consolidated Standards of Report-
ing Trials (CONSORT) statement (Extension for Pilot
and Feasibility Studies). Study results will be published
on ClinicalTrials.gov and in peer-reviewed literature.
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